Mosi-DF Eye Drop
Images are for reference. Actual packaging may vary.
Moxifloxacin (5mg) + Difluprednate (0.5mg)
Bottle of 5 ml • Syrup
A valid prescription is required for this medicine.
Haven’t found an alternative? A health advisor can help you understand what to do next.
We haven't found a cheaper matching alternative in our catalogue right now. Our health advisors can help you explore other options.
Active composition
+1 more active ingredient
Difluprednate inhibits the production of pro-inflammatory cytokines, reducing inflammation and pain in the eye.
Moxifloxacin inhibits DNA gyrase and topoisomerase IV, disrupting bacterial DNA replication and transcription.
Medical applications
Mosi-DF Eye Drop is a topical corticosteroid and antiproliferative agent combination product indicated for the treatment of inflammation and pain associated with cataract surgery and inflammatory postoperative ocular wounds. The product contains a fixed combination of moxifloxacin 5mg and difluprednate 0.5mg per 0.1mL. Moxifloxacin, a fluoroquinolone antibacterial agent, inhibits bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial DNA replication and transcription.
Difluprednate, a corticosteroid, reduces inflammation and pain by inhibiting the release of inflammatory mediators and suppressing the immune response. The combination of these two agents provides a synergistic effect in reducing inflammation and pain, making Mosi-DF Eye Drop a valuable adjunct to surgery in patients undergoing cataract surgery or treated for inflammatory postoperative ocular wounds.
The product is administered topically, three times a day, and may be used for up to 28 days.
Dosage information not available. Please consult your doctor or pharmacist.
Important precautions
Side-effect information is not available for this medicine. Please consult your doctor or pharmacist.
Information regarding the use of Mosi-DF Eye Drop during pregnancy is not available. Please consult your doctor.
High Risk
Mosi-DF Eye Drop should be used with caution during breastfeeding. Breastfeeding should be held until the treatment of the mother is completed and the drug is eliminated from her body.
Medical Advice
No interaction found/established
Exercise Caution
Mosi-DF Eye Drop may cause blurring of your vision for a short time just after its use. Do not drive until your vision is clear.
Consult Doctor
No interaction found/established
Regular Checkup
0 reviews for Mosi-DF Eye Drop







